William Perry, MD
Colon & Rectal Surgery · Rochester, MNNPI 1346801222
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,847 of the $3,873 with a category attached, or 73.5%. 6 manufacturers reported payments, led by THD America, Inc. at 44.1% of the total.
Across 20 payments — averaging $193.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- THD America, Inc.$2K
- Intuitive Surgical$1K
- Boston Scientific$595
- Axonics, Inc.$252
- RTI Surgical, Inc$218
- Teleflex LLC$26
What the payments were for
- Travel & lodging$2,84774%
- Food & beverage$1,02626%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| THD America, Inc. | 7 | $1,708 |
| Intuitive Surgical | 4 | $1,074 |
| Boston Scientific | 4 | $595 |
| Axonics, Inc. | 2 | $252 |
| RTI Surgical, Inc | 2 | $218 |
| Teleflex LLC | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,044
- Axonics$847
- BIODESIGN$126
How this compares
$3,873 in reported general payments places this provider in the 70th percentile of 64 colon & rectal surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 20 | $91 |
| Metronidazole | 18 | $18 |
| Ondansetron Hcl | 13 | $8 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Rochester
- Kellie MathisRochester$51K
- Sherief ShawkiRochester$49K
- David LarsonRochester$14K
- Barbara FollestadRochester$4K
- Brenda MurphyRochester$4K
- Rishi BatraRochester$4K
- Lindsey ZhangRochester$4K
- Ana Sofia Ore CarranzaRochester$3K
- Nicholas McKennaRochester$3K
- Kevin BehmRochester$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.